XPO1 and ischemic cardiomyopathy: The transcriptomic signature of these alterations has been found and has been identified that changes in gene expression, specifically of XPO1 that encodes EXP-1, were highly related to LV dysfunction in patients with ischemic cardiomyopathy [10].